Cedar Mountain Advisors, LLC Sarepta Therapeutics, Inc. Transaction History
Cedar Mountain Advisors, LLC
- $503 Million
- Q3 2025
A detailed history of Cedar Mountain Advisors, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Cedar Mountain Advisors, LLC holds 24 shares of SRPT stock, worth $560. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24Holding current value
$560% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
452Shares Held
82.9MCall Options Held
5.6MPut Options Held
4.19M-
Black Rock Inc. New York, NY10.3MShares$241 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$214 Million0.0% of portfolio
-
State Street Corp Boston, MA4.7MShares$110 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$105 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA2.53MShares$59.1 Million0.01% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $2.04B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...